Navigation Links
MRIGlobal, DHMRI Align in Strategic Collaboration
Date:7/11/2012

KANSAS CITY, Mo., July 11, 2012 /PRNewswire-USNewswire/ -- MRIGlobal today announced a joint marketing and business development agreement with the David H. Murdock Research Institute, a leading not-for-profit biotechnology research organization.

The agreement leverages research and development resources of both organizations to address challenges in food safety and biosurveillance.

"This agreement gives both organizations the opportunity to align resources to better tackle the challenges of monitoring the food supply chain and assuring safe, healthy products for consumers," said Robert Casillas, Ph.D., Vice President Strategic Life Sciences and National Security for MRIGlobal.

"We are excited to work with MRIGlobal to address these challenges. The depth of experience at both organizations enables us to provide benefits to both companies and consumers," said Steve Lommel, Ph.D., Interim President, David H. Murdock Research Institute. 

The David H. Murdock Research Institute, located in Kannapolis, N.C., focuses on research and development in agriculture, nutrition and human health.

MRIGlobal recently formed a new operating unit, Global Health and Security, which focuses on Biosurveillance and Food Safety as well as Medical Countermeasures, Diagnostics, and Drug Development and Repository Management.

About MRIGlobal
MRIGlobal, a not-for-profit research and development organization, delivers global solutions in national security and defense, energy and environment, life and animal sciences, agriculture and food safety, and transportation. The organization performs scientific research, advanced engineering and program integration and management for clients in government, industry and academia.  Established in 1944 as Midwest Research Institute, MRIGlobal is based in Kansas City, Mo., operates in nine states and Washington, D.C., and manages more than 3,300 employees.

MRIGlobal is one of two partners in the Alliance for Sustainable Energy, LLC, which manages and operates the National Renewable Energy Laboratory (NREL) in Golden, Colo., for the U.S. Department of Energy. For more information, visit www.mriglobal.org.

About the David H. Murdock Research Institute
The David H. Murdock Research Institute (DHMRI) is a non-profit, contract research organization committed to the improvement of human life. DHMRI provides collaborators groundbreaking research and development solutions at the intersection of human health, agriculture and nutrition. From the largest corporations, to life science start-ups and academic researchers, DHMRI combines collaboration and customized solutions to find the answers to advance research and product development. To learn more, visit www.dhmri.org.


'/>"/>
SOURCE MRIGlobal
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
2. WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
3. Karyopharm Therapeutics Announces Multiple Presentations on Selective Inhibitors of Nuclear Export (SINE) in Solid and Hematologic Malignancy Models and Spontaneous Canine Cancers at the American Association of Cancer Research (AACR) Meeting
4. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
5. Daiichi Sankyo And Coherus BioSciences Establish Strategic Collaboration To Develop And Commercialize Biosimilar Candidates
6. Genomic Health and OncoMed Announce Strategic Alliance for Biomarker Research and Discovery Using Next Generation Sequencing
7. Psyche Systems Corporation Signs Strategic Alliance with Siemens Healthcare to Provide Anatomic Pathology Solutions
8. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
9. Chemring Detection Systems Awarded $500k for Strategic Research and Development
10. SiREM and Tersus Environmental Form Strategic Marketing Alliance
11. Strategic Analysis of the Collagen Peptide Market in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... The BMT Tandem Meetings of ... International Blood & Marrow Transplant Research (CIBMTR) will take place Feb. 22-26, 2017 ... combined scientific sessions offer investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, ...
(Date:2/17/2017)... 17, 2017  If only one in every ... mutation-conferring resistance to chemotherapy, thousands of cancer cells ... focused on finding these mutations in ever-smaller subpopulations ... tumor DNA in blood — to guide treatment ... Unfortunately, however, detecting these genetic anomalies may ...
(Date:2/16/2017)... Feb. 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage ... find a better treatment for triple negative breast cancer (TNBC), ... France program. The YEi Start ... designed to help entrepreneurs grow their business in ... eight American companies selected to complete an intensive one week ...
(Date:2/16/2017)... Feb. 16, 2017   Capricor Therapeutics, Inc. ... biotechnology company developing first-in-class biological therapies for cardiac ... has elected to terminate its license agreement with ... agonists, including Cenderitide. "Our decision to ... we prioritize our efforts to advance our core ...
Breaking Biology Technology:
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, ... clinical-stage immuno-oncology company specializing in the development of ... the treatment of cancer and metastatic disease, announced ... and GMP manufacturing of a second clinical lot ... targeting folate receptor alpha. The manufactured vaccine product ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
(Date:1/25/2017)... YORK , Jan. 25, 2017 The ... Access Management (IAM) lifecycle is comprised of a ... for the purpose of maintaining digital identities and ... resources and applications. There are significant number of ... from time to time by optimizing processes and ...
Breaking Biology News(10 mins):